Cargando…
Coronavirus disease 2019 vaccines: landscape of global studies and potential risks
With the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, the importance of vaccines in epidemic prevention and public health has become even more obvious than ever. However, the emergence of multiple severe acute respiratory syndrome coronavirus 2 variants worldwide has raised concerns...
Autores principales: | Jiang, Hu-Da-Chuan, Tao, Yan-Yang, Jia, Si-Yue, Li, Jing-Xin, Zhu, Feng-Cai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440017/ https://www.ncbi.nlm.nih.gov/pubmed/34343152 http://dx.doi.org/10.1097/CM9.0000000000001688 |
Ejemplares similares
-
Global landscape of patents related to human coronaviruses
por: Liu, Kunmeng, et al.
Publicado: (2021) -
Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity
por: Bao, Pengtao, et al.
Publicado: (2023) -
The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world
por: Sharpe, Hannah R., et al.
Publicado: (2020) -
Insights Into the Changing Landscape of Coronavirus Disease 2019
por: Escobedo, Ruby A., et al.
Publicado: (2022) -
The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2
por: Zhu, James, et al.
Publicado: (2020)